Resomelagon (AP1189) is a potent, orally active
[1]. Montero-Melendez T, et, al. Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects. J Immunol. 2015 Apr 1;194(7):3381-8.
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical
















